Suarez et al v. Abbvie, Inc.

  1. March 21, 2023

    AbbVie Inks $2.7M Deal To End Humira FCA Kickback Battle

    AbbVie Inc. has agreed to pay $2.7 million to settle a whistleblower False Claims Act lawsuit accusing it of using unlawful kickbacks to encourage medical providers to prescribe its blockbuster drug Humira, according to a Tuesday filing in Illinois federal court.

  2. March 18, 2021

    AbbVie Loses Judge-Switch Bid In Humira Kickback Battles

    AbbVie Inc. lost a bid on Thursday to have a single judge handle a pair of closely watched fraud cases over allegations that the company illegally marketed its drug Humira, with an Illinois federal judge ruling that reassignment would significantly delay a whistleblower's False Claims Act case before her.

  3. March 16, 2021

    AbbVie Denies Judge-Shopping In Humira Kickback Cases

    AbbVie Inc. insisted Tuesday that its push for one judge to handle a pair of closely watched fraud cases has nothing to do with that judge rejecting kickback theories that another judge deemed viable, saying it merely desires consistency.

  4. November 30, 2020

    AbbVie Gets Humira Kickbacks FCA Suit Limited To Florida

    AbbVie Inc. on Monday partially beat a suit over an alleged kickback scheme to boost prescriptions of its blockbuster immunosuppressant drug Humira when an Illinois federal judge limited the case to only Florida-related allegations.

  5. November 01, 2018

    AbbVie Looks To Ditch FCA Suit Alleging Humira Kickbacks

    AbbVie Inc. has urged an Illinois federal judge to let it escape a False Claims Act suit over an alleged kickback scheme to boost prescriptions of its blockbuster immunosuppressant drug Humira through the use of a network of nurse "ambassadors."

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!